(Q44596999)

4 December 2017

title

Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study (English)

1 reference

4 December 2017

Ocular side‐effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow‐up study (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00116.X

14 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00116.X

14 March 2024

author name string

A-M Paakkala

2

1 reference

4 December 2017

Finnish Breast Cancer Group

5

1 reference

4 December 2017

M. Parkkari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510798

14 March 2024

L. Salminen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510798

14 March 2024

K. Holli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510798

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14510798

14 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-0420.2003.00116.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510798

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0420.2003.00116.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00116.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0420.2003.00116.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00116.X

14 March 2024

1 reference

4 December 2017

volume

81

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

495-499

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Specific changes in the fundus typical for the Sjögren-Larsson syndrome. An ophthalmological study of 35 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Toremifene. where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Ocular toxicity in low-dose tamoxifen: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Eye problems in breast cancer patients treated with tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Tamoxifen retinopathy in a male patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Retinopathy associated with low-dose tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Long-term tamoxifen citrate use and potential ocular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Tamoxifen retinopathy at low dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Canthaxanthin retinopathy. Anatomic and functional reversibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Screening for ocular toxicity in asymptomatic patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Long-term ocular manifestations in nephropathic cystinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Tamoxifen retinopathy. A clinicopathologic report

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Tamoxifen retinopathy: does it really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Effects of tamoxifen and toremifene on ALDH1 and ALDH3 in human retinal pigment epithelial cells and rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Ocular findings in primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Retinitis punctata albescens; a functional and diagnostic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Retinopathy caused by treatment with tamoxifen in low dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

Reversible ocular toxicity related to tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Tamoxifen retinopathy: a rare but serious complication

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Safety and Efficacy Results of a Randomized Trial Comparing Adjuvant Toremifene and Tamoxifen in Postmenopausal Patients With Node-Positive Breast Cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Tamoxifen retinopathy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Ocular manifestations of drug abuse

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Tamoxifen-associated eye disease. A review

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Bilateral optic neuritis evolved during tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Prevalence of map-dot-fingerprint changes in the cornea

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00116.X

7 January 2021

Ocular assessment of patients treated with tamoxifen

2

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00116.X

Macular Lesions in Alport's Disease

14 March 2024

38

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00116.X

14 March 2024

Identifiers

1 reference

4 December 2017

1 reference